• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Pernix Therapeutics Holdings, Inc. (PTX)

    -NasdaqGM
    10.73 Down 0.17(1.56%) Feb 27, 4:00PM EST
    Add to Portfolio
    Prev Close:10.90
    Open:10.84
    Bid:N/A
    Ask:11.44 x 1500
    1y Target Est:14.40
    Beta:2.68
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:10.72 - 11.00
    52wk Range:3.44 - 11.68
    Volume:630,830
    Avg Vol (3m):501,939
    Market Cap:411.39M
    P/E (ttm):N/A
    EPS (ttm):-0.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PTX

    Comparison

    Symbol% ChgMkt Cap
    PTXDown 1.56%411.39M
    JNJDown 0.28%285.03B
    PFEDown 0.78%216.24B

    Key Statistics

    Forward P/E (1 yr):7.78
    P/S (ttm):3.43
    Ex-Dividend Date:21-Aug-01

    Analysts

    Annual EPS Est (Dec-15) :0.92
    Quarterly EPS Est (Mar-15) :0.18
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.49

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback